The present invention relates to novel N-cyanomethyl amides which are cysteine protease inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.

Die anwesende Erfindung bezieht auf Roman N-cyanomethyl Amiden, die Cysteineproteasehemmnisse, die pharmazeutisch annehmbaren Salze und N-Oxide davon sind, ihrem Gebrauch als therapeutische Mittel und den Methoden ihres Bildens.

 
Web www.patentalert.com

< Compounds and methods for inhibiting cancer metastasis

< .beta.3-adrenoreceptor agonists, agonist compositions and methods of making and using the same

> Apoptosis inducers

> RECOMBINANT DNA COMPRISING DNA CODING FOR MYOSIN HEAVY CHAIN SM1 ISO-FORM PROTEIN INSERTED INTO VECTOR DNA MICROORGANISM CARRYING THE RECOMBINANT DNA, AND AN AGENT FOR TREATMENT OF ARTERIOSCLEROSIS COMPRISING THE RECOMBINANT DNA

~ 00079